Protalix BioTherapeutics, Inc.

Regulatory Filings • Feb 5, 2007

8-K 1 e26230_8k.htm FORM 8-K MARKER FORMAT-SHEET="Center Head 2-Bold" FSL="Workstation"

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

MARKER FORMAT-SHEET="Cutoff rule centered" FSL="Workstation" MARKER FORMAT-SHEET="Center Head 3 Bold" FSL="Workstation"

FORM 8-K

MARKER FORMAT-SHEET="Center Head 3 Bold" FSL="Workstation"

CURRENT REPORT

MARKER FORMAT-SHEET="Center Head 3 Bold" FSL="Workstation"

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

MARKER FORMAT-SHEET="Cutoff rule centered" FSL="Workstation" MARKER FORMAT-SHEET="Para Flush 00" FSL="Workstation"

Date of Report (Date of earliest event reported): January 31, 2007

MARKER FORMAT-SHEET="Center Head 3 Bold" FSL="Workstation"

Orthodontix, Inc. (Exact name of registrant as specified in its charter)

MARKER FORMAT-SHEET="8K 3 col" FSL="Workstation"

Florida (State or other jurisdiction of incorporation) 000-27836 (Commission File Number) 65-0643773 (IRS Employer Identification No.)

MARKER FORMAT-SHEET="Center Head 2-Bold" FSL="Workstation"

2 Snunit Street Science Park POB 455 Carmiel, Israel 21000

MARKER FORMAT-SHEET="Center no bold" FSL="Workstation"

(Address of principal executive offices) (Zip Code) MARKER FORMAT-SHEET="Center no bold" FSL="Workstation"

1428 Brickell Avenue, Suite 105, Miami, Florida 33131 MARKER FORMAT-SHEET="Cutoff rule centered" FSL="Workstation"

MARKER FORMAT-SHEET="Center no bold" FSL="Workstation"

(Former Name or Former Address, if Changed Since Last Report) MARKER FORMAT-SHEET="Para Flush 00" FSL="Workstation"

Registrant’s telephone number, including area code: (305) 371-4112

MARKER FORMAT-SHEET="Para Flush 00" FSL="Workstation"

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

MARKER FORMAT-SHEET="Para Hang 05" FSL="Workstation"

|_| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

MARKER FORMAT-SHEET="Para Hang 05" FSL="Workstation"

|_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

MARKER FORMAT-SHEET="Para Hang 05" FSL="Workstation"

|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

MARKER FORMAT-SHEET="Para Hang 05" FSL="Workstation"

|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

MARKER FORMAT-SHEET="5 pt rule no space" FSL="Workstation" *********** MARKER PAGE="sheet: 5; page: 5" MARKER FORMAT-SHEET="Left Head 2 Bold" FSL="Workstation"

Item 3.02. Unregistered Sales of Equity Securities

MARKER FORMAT-SHEET="Para Indent 00" FSL="Workstation"

On January 31, 2007, the holders of certain outstanding warrants of Orthodontix, Inc. (the “Company”), exercised warrants to purchase, in the aggregate, 3,875,416 shares of the Company’s common stock, par value $0.001 per share (“Common Stock”). The exercising holders were Stephen H. Bittel, Ernest M. Halpryn, Glenn L. Halpryn, IVC Investors Ltd., Steven J. Glauser Trust, Frost Gamma Investment Trust, Dr. Jane Hsiao, Steven D. Rubin, Subbarao Uppaluri, Ann D. Singer Revocable Trust Agreement Dated 2/18/1998, Dr. Joseph S. Levy Revocable Trust Dated June 17, 1998 and Carole R. Levy Revocable Trust Dated June 17, 1998.

MARKER FORMAT-SHEET="Para Indent 00" FSL="Workstation"

The exercise price of the warrants was $1.376 per share. The aggregate exercise price of the shares of Common Stock issued in connection with the exercise of the warrants was $5,332,572.42.

MARKER FORMAT-SHEET="Para Indent 00" FSL="Workstation"

No broker-dealers were involved in the sale and no commissions were paid by the Company. The issuances of the shares of Common Stock were exempt from the registration requirements of the Securities Act of 1933, as amended, pursuant to Section 4(2) of such Act.

MARKER FORMAT-SHEET="Page Break CENTER" FSL="Workstation"

2

*********** MARKER PAGE="sheet: 6; page: 6" MARKER FORMAT-SHEET="Center Head 2-Bold" FSL="Workstation"

SIGNATURES

MARKER FORMAT-SHEET="Para Indent 00" FSL="Workstation"

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

MARKER FORMAT-SHEET="Para Flush 20" FSL="Workstation"

ORTHODONTIX, INC.

MARKER FORMAT-SHEET="Para Flush 20" FSL="Workstation"

(Registrant)

MARKER FORMAT-SHEET="Para Flush 20" FSL="Workstation"

Date: February 5, 2007 By: /s/ David Aviezer Name: David Aviezer, Ph.D. Title: President and Chief Executive Officer

MARKER FORMAT-SHEET="Page Break CENTER" FSL="Workstation"

3